Schorno Dean L 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Schorno Dean L（CIK 1509688）在 1 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-09-03）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 卖出 | 928 | $44,080 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 694 | $8,814 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 620 | $11,594 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 2,000 | $48,400 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 1,286 | $31,121 |
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 1,200 | $22,440 |
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 2,181 | $27,699 |
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 卖出 | 928 | $27,710 |
| 2026-02-19 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 20,636 | $0 |
| 2026-02-12 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 卖出 | 3,546 | $122,763 |
| 2026-02-04 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 卖出 | 5,488 | $197,623 |
| 2025-12-29 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 1,987 | $39,740 |
| 2025-12-29 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 2,846 | $68,873 |
| 2025-12-29 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | 买入 | 1,667 | $31,173 |
来源：SEC Form 4 申报文件 · 截至 2026-09-03